Science Stock Today

SSAA
 Stock
  

USD 9.81  0.01  0.10%   

Market Performance
1 of 100
Odds Of Distress
Over 75
Science Strategic is trading at 9.81 as of the 4th of July 2022, a 0.10% increase since the beginning of the trading day. The stock's open price was 9.8. Science Strategic has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Science Strategic Acquisition are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of July 2020 and ending today, the 4th of July 2022. Click here to learn more.
Fiscal Year End
December
IPO Date
22nd of March 2021
Category
Financial Services
ISIN
US8086411043
It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company has 31.05 M outstanding shares of which 3.08 K shares are at this time shorted by private and institutional investors with about 0.21 trading days to cover. More on Science Strategic Acquisition
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Science Strategic Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Science Strategic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Science Strategic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Science Strategic has high likelihood to experience some financial distress in the next 2 years
The company has a current ratio of 0.34, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Science Strategic until it has trouble settling it off, either with new capital or with free cash flow. So, Science Strategic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Science Strategic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Science to invest in growth at high rates of return. When we think about Science Strategic's use of debt, we should always consider it together with cash and equity.
Science Strategic Acquisition currently holds about 346.32 K in cash with (557.93 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Over 86.0% of the company shares are owned by institutional investors
Latest headline from seekingalpha.com: Vishay Intertechnology A Deep Dive Into A Value Trap - Seeking Alpha
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Science Strategic's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Science Strategic Acquisition (SSAA) is traded on NASDAQ Exchange in USA . The company currently falls under 'Small-Cap' category with current market capitalization of 380.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Science Strategic's market, we take the total number of its shares issued and multiply it by Science Strategic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Science Strategic conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 31.05 M outstanding shares of which 3.08 K shares are at this time shorted by private and institutional investors with about 0.21 trading days to cover. Science Strategic Acquisition currently holds about 346.32 K in cash with (557.93 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Science Strategic Probability Of Bankruptcy
Ownership
Science Strategic maintains a total of 31.05 Million outstanding shares. The majority of Science Strategic outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Science Strategic to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Science Strategic. Please pay attention to any change in the institutional holdings of Science Strategic Acquisition as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Science Ownership Details

Science Stock Price Odds Analysis

What are Science Strategic's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Science Strategic jumping above the current price in 90 days from now is about 25.11%. The Science Strategic Acquisition probability density function shows the probability of Science Strategic stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Science Strategic has a beta of 0.0062. This usually implies as returns on the market go up, Science Strategic average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Science Strategic Acquisition will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Science Strategic is significantly underperforming DOW.
  Odds Below 9.81HorizonTargetOdds Above 9.81
69.49%90 days
 9.81 
25.11%
Based on a normal probability distribution, the odds of Science Strategic to move above the current price in 90 days from now is about 25.11 (This Science Strategic Acquisition probability density function shows the probability of Science Stock to fall within a particular range of prices over 90 days) .

Science Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Science Strategic that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Science Strategic's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Science Strategic's value.
InstituionSecurity TypeTotal SharesValue
Glazer Capital LlcCommon Shares1.8 M18 M
Marshall Wace LlpCommon Shares1.5 M14.5 M
View Science Strategic Diagnostics

Science Strategic Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Science Strategic market risk premium is the additional return an investor will receive from holding Science Strategic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Science Strategic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Science Strategic's alpha and beta are two of the key measurements used to evaluate Science Strategic's performance over the market, the standard measures of volatility play an important role as well.

Science Stock Against Markets

Picking the right benchmark for Science Strategic stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Science Strategic stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Science Strategic is critical whether you are bullish or bearish towards Science Strategic Acquisition at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Science Strategic without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Investing Science Strategic Acquisition

You need to understand the risk of investing before taking a position in Science Strategic. The danger of trading Science Strategic Acquisition is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Science Strategic is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Science Strategic. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Science Strategic is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.23
Market Capitalization
380.4 M
Return On Assets
-0.0118
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.